Population studies on breast cancer samples revealed a correlation between NF1 loss and upregulation of estrogen receptor (ER)-associated pathways in human breast cancer tissues, as well as increased ER activity in rat models of mammary adenocarcinoma (Dischinger et al., 2018). Here, ESR1 is linked to breast carcinoma.